From: Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer
Variable | Categorization | n analyzable | % |
---|---|---|---|
Total n = 174 | |||
Clinico-pathologic data: | |||
Age at diagnosis (median, range) | 69,5 years (32–92) | ||
<70 years | 87 | 50.0 | |
≥70 years | 87 | 50.0 | |
Sex | |||
Female | 43 | 24.7 | |
Male | 131 | 75.3 | |
Tumor stage (WHO 1973a) | |||
pTa | 90 | 51.7 | |
pT1 | 68 | 39.1 | |
pT2 | 13 | 7.5 | |
pT3 | 2 | 1.1 | |
pT4 | 1 | 0.6 | |
Histologic grade (WHO 1973a) | |||
G1 | 44 | 25.3 | |
G2 | 87 | 50.0 | |
G3 | 43 | 24.7 | |
Histologic grade (WHO 2004b) | |||
Low grade | 101 | 58.0 | |
High grade | 73 | 42.0 | |
Adjacent carcinoma in situ | |||
No | 158 | 90.8 | |
Yes | 16 | 9.2 | |
Multiplicity | |||
Solitary | 124 | 71.3 | |
Multifocal | 50 | 28.7 | |
Growth pattern | |||
Papillary | 159 | 91.4 | |
Solid | 15 | 8.6 | |
Immunohistochemistry (IHC): | |||
HDAC-1 | |||
Low expression | 104 | 59.8 | |
High expression | 70 | 40.2 | |
HDAC-2 | |||
Low expression | 101 | 58.0 | |
High expression | 73 | 42.0 | |
HDAC-3 | |||
Low expression | 71 | 40.8 | |
High expression | 103 | 59.2 |